论文部分内容阅读
目的观察分析临床治疗重度子痫前期的效果,总结其临床应用价值。方法选取我院2009年4月至2011年4月60例重度子痫前期的患者,随机分为观察组和对照组,各30例,观察组应用硫酸镁联合低分子肝素治疗,对照组单纯应用硫酸镁治疗,观察对比两组患者的血压、血脂、尿量指标及母儿结局。结果观察组患者的血压、血脂水平与对照组相比下降幅度更为明显,尿量明显增加,两组比较差异显著(P<0.05),具有统计学意义。结论应用硫酸镁联合低分子肝素治疗重度子痫前期的效果显著,明显优于单纯应用硫酸镁治疗,能够有效缓解患者的临床症状,降低患者血压、血脂水平,减少产后并发症的发生,全面改善母婴的预后,最大限度地保障母婴安全。
Objective To observe the effect of clinical treatment of severe preeclampsia and summarize its clinical value. Methods Sixty patients with severe preeclampsia from April 2009 to April 2011 in our hospital were randomly divided into observation group (30 cases) and control group (30 cases each). The observation group was treated with magnesium sulfate and low molecular weight heparin. The control group Magnesium sulfate treatment, observed and compared two groups of patients blood pressure, blood lipid, urine output and maternal and child outcomes. Results In the observation group, the blood pressure and blood lipid levels decreased more obviously than those in the control group, and the urine output increased significantly. There was significant difference between the two groups (P <0.05), which was statistically significant. Conclusion The application of magnesium sulfate combined with low molecular weight heparin treatment of severe preeclampsia was significantly better than the simple application of magnesium sulfate treatment can effectively alleviate the clinical symptoms of patients with lower blood pressure and blood lipid levels and reduce the incidence of postpartum complications and overall improvement Mother and child prognosis, to maximize the protection of mother and child safety.